Non-invasive evaluation of liver fibrosis using transient elastography

Slides:



Advertisements
Similar presentations
Measurement of liver fibrosis Amar Dhillon Royal Free and University College Medical School.
Advertisements

Non-Invasive Liver Testing
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Volume 63, Issue 1, Pages (July 2015)
Figure 1 Proposed risk stratification for patients with NAFLD
Volume 138, Issue 1, Pages e1 (January 2010)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
Volume 41, Issue 6, Pages (December 2004)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 67, Issue 3, Pages (September 2017)
Volume 50, Issue 4, Pages (April 2009)
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice  Parambir.
Update on ultrasound imaging of liver fibrosis
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 128, Issue 2, Pages (February 2005)
Volume 150, Issue 1, Pages (January 2016)
Non-invasive diagnosis of non-alcoholic fatty liver disease
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
Immigration and viral hepatitis
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Virological tools to diagnose and monitor hepatitis C virus infection
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
Supersonic Shear Imaging and Transient Elastography With the XL Probe Accurately Detect Fibrosis in Overweight or Obese Patients With Chronic Liver Disease 
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
New imaging techniques for liver diseases
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Liver cancer: Approaching a personalized care
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Hepatic hepcidin expression is decreased in cirrhosis and HCC
Volume 65, Issue 6, Pages (December 2016)
Volume 138, Issue 1, Pages e1 (January 2010)
EASL Clinical Practice Guidelines: Wilson’s disease
Pierre Nahon, Jessica Zucman-Rossi  Journal of Hepatology 
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 60, Issue 1, Pages (January 2014)
The heart in liver transplantation
Clinical states of cirrhosis and competing risks
Reply to: “It takes two “eyes” to see in depth”
Volume 50, Issue 4, Pages (April 2009)
Volume 132, Issue 2, (February 2007)
Immigration and viral hepatitis
Evolution of liver transplantation for hepatocellular carcinoma
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
Chronic hepatitis B in children and adolescents
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Volume 142, Issue 6, Pages e4 (May 2012)
Laurent Castera, Mireen Friedrich-Rust, Rohit Loomba  Gastroenterology 
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Raymond D’Souza, Michael J
Volume 39, Issue 3, Pages (September 2003)
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Non-invasive evaluation of liver fibrosis using transient elastography Laurent Castera, Xavier Forns, Alfredo Alberti  Journal of Hepatology  Volume 48, Issue 5, Pages 835-847 (May 2008) DOI: 10.1016/j.jhep.2008.02.008 Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 1 (A) Position of probe and explored volume (Imaging from Echosens). (B) Shear wave propagation velocity according to the severity of hepatic fibrosis (Metavir score). The elastic modulus E expressed as E=3ρV2, where V is the shear velocity and ρ is the mass density (constant for tissues): the stiffer the tissue, the faster the shear wave propagates. Hence, for absent fibrosis (F0), velocity is 1.0m/s and elasticity is 3kPa, whereas for cirrhosis (F4) velocity is 3.0m/s and elasticity is 27kPa. Adapted from Sandrin et al. [13]. Journal of Hepatology 2008 48, 835-847DOI: (10.1016/j.jhep.2008.02.008) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Distribution of liver stiffness values in 429 healthy subjects without overt causes of liver disease and normal liver enzymes, according to the presence or the absence of metabolic syndrome. Adapted from Roulot et al. [25]. Journal of Hepatology 2008 48, 835-847DOI: (10.1016/j.jhep.2008.02.008) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Box-plots of liver stiffness values for each fibrosis stage (Metavir). Because of the wide range of FS values for F4, the vertical axis is in logarithmic scale. Adapted from (A) Ziol et al. [18] and (B) Castera et al. [17]. Journal of Hepatology 2008 48, 835-847DOI: (10.1016/j.jhep.2008.02.008) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Proposed algorithm for clinical practice combining FibroScan and Fibrotest as first-line assessment of hepatic fibrosis in patients with chronic hepatitis C. Adapted from Castera et al. [17]. Journal of Hepatology 2008 48, 835-847DOI: (10.1016/j.jhep.2008.02.008) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 5 (A) Relationship between liver stiffness and portal pressure in a cohort of 124 HCV-infected liver transplant recipients who underwent 129 paired hepatic venous pressure gradient (HVPG) and liver stiffness measurements. Patients are grouped according to the HVPG value (x axis): normal portal pressure (HVPG<6mmHg), mild portal hypertension (HVPG=6–9.9mmHg), and clinically significant portal hypertension (HVPG⩾10mmHg). Adapted from Garcia-Samanego & Forns [56]. (B) Linear regression analysis between HVPG and liver stiffness values in 61 HCV patients. Adapted from Vizzutti et al. [52]. Journal of Hepatology 2008 48, 835-847DOI: (10.1016/j.jhep.2008.02.008) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 6 Clinical significance of liver stiffness cut-offs in chronic liver diseases. When liver stiffness values range between 2.5 and 7kPa, mild or absent fibrosis is likely, whereas when liver stiffness values are above 12.5kPa, cirrhosis is likely. Journal of Hepatology 2008 48, 835-847DOI: (10.1016/j.jhep.2008.02.008) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions